Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


APPLE ROBERT F Create: Alert

All | News | Filings
Date FiledTypeDescription
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 76,893 shares @ $0
Paid exercise price by delivering 34,282 shares @ $3.66, valued at $125.5k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 402,930 shares @ $2.73, valued at $1.1M
Paid exercise price by delivering 40,892 shares @ $2.78, valued at $113.7k
Granted 776,617 options to buy @ $2.73, valued at $2.1M
06/09/2020 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 48,936 shares @ $3.12, valued at $152.7k
Paid exercise price by delivering 44,223 shares @ $3.13, valued at $138.4k
02/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/11/2019 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Sold 100,000 shares @ $4.6783, valued at $467.8k
Sold 97,000 shares @ $4.6228, valued at $448.4k
Sold 110,000 shares @ $4.5766, valued at $503.4k
Sold 1,000 shares @ $4.75, valued at $4.8k
Sold 58,524 shares @ $4.7563, valued at $278.4k
Exercised 100,000 options to buy @ $1.52, valued at $152k
Exercised 97,000 options to buy @ $1.66, valued at $161k
Exercised 110,000 options to buy @ $2.94, valued at $323.4k
Exercised 1,000 options to buy @ $3.96, valued at $4k
Exercised 58,524 options to buy @ $3.96, valued at $231.8k
11/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2019 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 282,534 shares @ $2.92, valued at $825k
Granted 567,423 options to buy @ $2.92, valued at $1.7M
06/11/2019 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 48,936 shares @ $2.81, valued at $137.5k
Paid exercise price by delivering 44,225 shares @ $2.81, valued at $124.3k
06/04/2019 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 52,559 shares @ $2.79, valued at $146.6k
02/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/23/2018 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Sold 43,000 shares @ $3.75, valued at $161.3k
Exercised 43,000 options to buy @ $0.47, valued at $20.2k
06/11/2018 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 32,031 shares @ $2.7, valued at $86.5k
Granted 305,556 shares @ $2.7, valued at $825k
Granted 591,510 options to buy @ $2.7, valued at $1.6M
06/05/2018 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 34,402 shares @ $2.69, valued at $92.5k
05/30/2018 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 13,480 shares @ $2.43, valued at $32.8k
05/14/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2018 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 113,835 shares @ $0
Paid exercise price by delivering 37,001 shares @ $2.2, valued at $81.4k
06/12/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
06/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/05/2017 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Sold 37,000 shares @ $3.0019, valued at $111.1k
Sold 3,000 shares @ $3, valued at $9k
Exercised 37,000 options to buy @ $1.65, valued at $61.1k
Exercised 3,000 options to buy @ $1.65, valued at $5k
12/29/2016 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Exercised 60,000 shares @ $1.23, valued at $73.8k
Paid exercise price by delivering 39,717 shares @ $2.35, valued at $93.3k
Exercised 60,000 options to buy @ $1.23, valued at $73.8k
06/30/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/06/2016 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 363,150 shares @ $1.12, valued at $406.7k
Granted 773,700 options to buy @ $1.12, valued at $866.5k
06/01/2016 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 3,526 shares @ $0.86, valued at $3k
Paid exercise price by delivering 14,903 shares @ $0.92, valued at $13.7k
Paid exercise price by delivering 3,389 shares @ $0.92, valued at $3.1k
03/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/11/2016 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 250,000 options to buy @ $0.88, valued at $220k
10/16/2013 4 APPLE ROBERT F (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Sold 22,000 shares @ $5.0545, valued at $111.2k
Exercised 22,000 options to buy @ $0.47, valued at $10.3k
06/05/2013 4 APPLE ROBERT F (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Sold 86,400 shares @ $4.0138, valued at $346.8k
Sold 28,600 shares @ $4.0254, valued at $115.1k
Exercised 86,400 options to buy @ $0.47, valued at $40.6k
Exercised 28,600 options to buy @ $0.47, valued at $13.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy